Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02978586 · ClinicalTrials.gov registry record
A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors
A clinical trial of Breast Cancer and Prostate Cancer, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT02978586: Completed study of Breast Cancer and Prostate Cancer, sponsored by Case Comprehensive Cancer Center.
NCT02978586 is a study of Breast Cancer and Prostate Cancer that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 8 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02978586, a study of Breast Cancer and Prostate Cancer, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if positron emission tomography/ magnetic resonance imaging (PET/MRI) can be used to monitor the effectiveness of cancer treatment using an investigational radioactive drug called \[Ga-68\]PSMA.
Primary Outcome
The outcome measure for the statistical analysis of the test-retest reproducibility will be concordance analysis of standard uptake values (SUVs) between the 2 baseline scans
Conditions Studied
Interventions
- DEVICE [Ga-68]PSMA PET/MR
Study Locations (1)
Ohio
- University Hospitals, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-03-14 |
| Est. Completion | 2019-10-25 |
What the finished NCT02978586 record still lists
NCT02978586 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which [Ga-68]PSMA PET/MR is the first listed.
NCT02978586 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02978586 about?
NCT02978586 is a clinical study titled "A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors". The purpose of this study is to see if positron emission tomography/ magnetic resonance imaging (PET/MRI) can be used to monitor the effectiveness of cancer treatment using an investigational radioactive drug called \[Ga-68\]PSMA.
What is the current status of trial NCT02978586?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2018-03-14. Estimated completion is 2019-10-25.
What conditions does trial NCT02978586 study?
This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Lung Cancer, Prostate-specific Membrane Antigen Positive Tumors.
What interventions are being tested in trial NCT02978586?
The interventions under investigation include: [Ga-68]PSMA PET/MR (DEVICE).
Who is sponsoring clinical trial NCT02978586?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02978586 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02978586's enrollment target sits among peer trials
8 1196th of 1224 higher than 24 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI